MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Clinical trials for MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1 explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1 trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug enters human testing for Tough-to-Treat blood cancers
Disease control OngoingThis is a first-in-human study to find a safe dose of an experimental antibody drug called Hu8F4 for patients with advanced blood cancers like leukemia and myelodysplastic syndrome (MDS). The main goals are to check for side effects and see how the body processes the drug. The st…
Matched conditions: MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Race to find better treatment for High-Risk blood cancers
Disease control OngoingThis study is testing whether adding one of two other drugs (lenalidomide or vorinostat) to the standard chemotherapy drug azacitidine works better for people with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to see which comb…
Matched conditions: MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC